Under Trump, U.S. Companies Face a Rough Road on Trade

Under Trump, U.S. Companies Face a Rough Road on Trade-politico: In October 2015, as President Barack Obama was hoping to rush the newly signed Trans-Pacific Partnership trade deal through Congress, he invited leaders of the pharmaceutical industry in the White House. The industry had emerged as a key obstacle to the largest free trade agreement in history, insisting that TPP didn’t provide enough protection for an expensive class of nature-based drugs called biologics.